Case Report: Immunotherapy-induced myocarditis requiring pacemaker insertion in an older adult. what happens if we rechallenge?

Immune checkpoint inhibitors (ICIs) have revolutionized the practice of oncology, becoming a cornerstone treatment for many cancers. Nivolumab, an antibody-targeting programmed cell death protein-1 (PD-1), and ipilimumab, an antibody-targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), ar...

Descrición completa

Detalles Bibliográficos

Principais autores:	Wassim Assaad, Nour El Meski, Omar Fakhreddine, Tarek El Halabi, Marwan Refaat, Firas Kreidieh
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-02-01
Series:	Frontiers in Oncology
Assuntos:	case report immune-checkpoint inhibitors immunotherapy myocarditis rechallenge renal cell carcinoma
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1565918/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!